In the BioHarmony Drug Report Database

"Preview" Icon

Zaleplon

Sonata (zaleplon) is a small molecule pharmaceutical. Zaleplon was first approved as Sonata on 1999-08-13. It is used to treat sleep initiation and maintenance disorders in the USA.

 

Trade Name

 

Sonata
 

Common Name

 

zaleplon
 

ChEMBL ID

 

CHEMBL1521
 

Indication

 

sleep initiation and maintenance disorders
 

Drug Class

 

Non-benzodiazepine anxiolytics, sedatives, hypnotics

Image (chem structure or protein)

Zaleplon structure rendering